Stock 603896 ZHEJIANG SHOUXIANGU PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

Equities

603896

CNE100002XJ4

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 24/06/2024 BST 		5-day change 1st Jan Change
22.8 CNY -3.18% Intraday chart for Zhejiang Shouxiangu Pharmaceutical Co., Ltd. -9.31% -29.28%
04-25 Zhejiang Shouxiangu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
2023 Zhejiang Shouxiangu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 5,042 8,835 7,821 6,391 4,520 - -
Enterprise Value (EV) 1 5,042 8,835 7,821 6,391 3,085 2,767 2,523
P/E ratio 32.8 x 43.3 x 27.7 x 24.8 x 15.9 x 13 x 12 x
Yield - 0.7% 1.11% 1.21% 1.95% 2.34% 2.57%
Capitalization / Revenue - 11.5 x 9.43 x 8.15 x 5.19 x 4.39 x 4.15 x
EV / Revenue - 11.5 x 9.43 x 8.15 x 3.54 x 2.69 x 2.31 x
EV / EBITDA - - 22 x - 9.29 x 7.52 x 6.28 x
EV / FCF - - - - - - -
FCF Yield - - - - - - -
Price to Book - 5.46 x 4.3 x 3.1 x 1.87 x 1.71 x 1.55 x
Nbr of stocks (in thousands) 186,581 198,015 197,198 198,244 198,244 - -
Reference price 2 27.02 44.62 39.66 32.24 22.80 22.80 22.80
Announcement Date 31/03/21 27/01/22 03/03/23 25/04/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 767.1 829.1 784.3 870.5 1,029 1,090
EBITDA 1 - - 354.9 - 332 368 402
EBIT 1 - 207.2 280.9 254.7 277.5 345 365
Operating Margin - 27% 33.88% 32.48% 31.88% 33.53% 33.49%
Earnings before Tax (EBT) 1 - 201.1 278 254.9 289.5 354.7 384.5
Net income 1 151.5 200.8 277.8 254.5 288.7 354.6 383.5
Net margin - 26.18% 33.51% 32.44% 33.16% 34.46% 35.18%
EPS 2 0.8231 1.031 1.430 1.300 1.430 1.760 1.905
Free Cash Flow - - - - - - -
FCF margin - - - - - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share 2 - 0.3115 0.4400 0.3900 0.4450 0.5333 0.5850
Announcement Date 31/03/21 27/01/22 03/03/23 25/04/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - -
Net Cash position 1 - - - - 1,435 1,753 1,997
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - - - - - - -
ROE (net income / shareholders' equity) - 13.5% 16.1% 12.4% 12.2% 13.7% 13.1%
ROA (Net income/ Total Assets) - - 9.73% - 9.05% 9.7% 10.1%
Assets 1 - - 2,856 - 3,190 3,655 3,797
Book Value Per Share 2 - 8.170 9.210 10.40 12.20 13.30 14.70
Cash Flow per Share 2 - 1.520 1.730 1.560 1.630 1.930 2.160
Capex 1 - 162 182 415 73 87 102
Capex / Sales - 21.06% 22% 52.85% 8.39% 8.45% 9.36%
Announcement Date 31/03/21 27/01/22 03/03/23 25/04/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
22.8 CNY
Average target price
55.6 CNY
Spread / Average Target
+143.86%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

1st Jan change Capi.
ZHEJIANG SHOUXIANGU PHARMACEUTICAL CO., LTD. Stock Zhejiang Shouxiangu Pharmaceutical Co., Ltd.
-29.28% 622M
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+29.76% 5.69B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-32.34% 3.53B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
-2.23% 3.06B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-25.26% 2.62B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-10.88% 2.29B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+40.09% 1.86B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD Stock Zhejiang Jolly Pharmaceutical Co.,LTD
+40.90% 1.43B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
-15.16% 1.41B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK Stock PT Industri Jamu dan Farmasi Sido Muncul Tbk
+42.86% 1.4B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. 603896 Stock
  4. Financials Zhejiang Shouxiangu Pharmaceutical Co., Ltd.